MedPath

Investigation of the anti-inflammatory effects of heparin in mechanically ventilated patients

Phase 3
Conditions
Mechanical Ventilation.
Other postprocedural respiratory disorders
Registration Number
IRCT201701011497N6
Lead Sponsor
Vice Chancellor for Research,Isfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients who require invasive mechanical ventilation for more than 48 hours.
Exclusion criteria:If patients receive mechanical ventilation for more than 24 hours prior to enrollment; has required mechanical ventilation for more than 48 hours in previous admission in ICU during the current hospital admission; allergy to heparin (including any history of heparin-induced thrombocytopenia); a pulmonary hemorrhage in the previous 3 months; uncontrolled bleeding or a significant bleeding disorder; an intracranial hemorrhage in the past 12 months; or an epidural catheter in place or likely to be placed in the next 48 hours and are younger than 18 years old.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in ratio of partial pressure of oxygen to FiO2 (PaO2/FiO2). Timepoint: during the 5 days of study. Method of measurement: ratio of PaO2/FiO2.
Secondary Outcome Measures
NameTimeMethod
(RSBI)RAPID SHALLOW BREATHING INDEX. Timepoint: during 5 days of study. Method of measurement: ratio of tidal volume to respiratory rate.
© Copyright 2025. All Rights Reserved by MedPath